{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:25:03Z","timestamp":1792697103052,"version":"4.5.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Red blood cell (RBC) transfusions are critical for treatment and prevention of complications of sickle cell disease (SCD), and most SCD patients will receive 1 or more transfusions by age 20. However, SCD alloimmunization remains a serious complication of transfusions that can lead to life-threatening acute and delayed transfusion reactions. Alloimmunization rates are higher in SCD patients most likely due to RBC antigenic differences between largely white donors vs mainly African-American recipients and frequency of transfusions. However, it remains unclear why some but not all SCD patients develop alloantibodies. Cellular immune responses that differ between alloimmunized and nonalloimmunized SCD patients are beginning to be characterized. Altered CD4+ T helper cell responses, known to control immunoglobulin G production, have been identified in alloimmunized SCD patients, including abnormalities in regulatory T cells, as well as helper type 1 (TH1), TH17, and follicular helper T cells. Furthermore, heightened innate immune cell responses to cell free heme with cell polarization toward proinflammatory T cell profiles were recently reported in SCD antibody responders, suggesting that the ongoing hemolytic state in SCD may impair the ability of innate immune cells in these already alloimmunized patients to counter alloimmunization. Identification of molecular pathways in key cellular components that differ between alloimmunized and nonalloimmunized SCD patients is likely to lead to identification of biomarkers of alloimmunization and future design of targeted therapies to prevent or even dampen alloantibody responses in these highly susceptible patients.<\/jats:p>","DOI":"10.1182\/asheducation-2016.1.457","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T16:05:27Z","timestamp":1480694727000},"page":"457-461","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Immunoregulatory networks in sickle cell alloimmunization"],"prefix":"10.1182","volume":"2016","author":[{"given":"Karina","family":"Yazdanbakhsh","sequence":"first","affiliation":[{"name":"Laboratory of Complement Biology, New York Blood Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111706060778000_B1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"7","key":"2019111706060778000_B2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"issue":"3","key":"2019111706060778000_B3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111706060778000_B4","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2019111706060778000_B5","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","article-title":"Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells","volume":"175","author":"Lim","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"2019111706060778000_B6","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.4049\/jimmunol.0901163","article-title":"Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus","volume":"183","author":"Iikuni","year":"2009","journal-title":"J Immunol"},{"key":"2019111706060778000_B7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol"},{"issue":"12","key":"2019111706060778000_B8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.22167","article-title":"Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and \u03b2-thalassemia major","volume":"86","author":"Bao","year":"2011","journal-title":"Am J Hematol"},{"issue":"3","key":"2019111706060778000_B9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajh.23629","article-title":"Partial dysfunction of Treg activation in sickle cell disease","volume":"89","author":"Vingert","year":"2014","journal-title":"Am J Hematol"},{"key":"2019111706060778000_B10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fimmu.2012.00165","article-title":"Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance","volume":"3","author":"Kornete","year":"2012","journal-title":"Front Immunol"},{"issue":"9","key":"2019111706060778000_B11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.23488","article-title":"Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease","volume":"88","author":"Bao","year":"2013","journal-title":"Am J Hematol"},{"issue":"6","key":"2019111706060778000_B12","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood-2008-03-146415","article-title":"Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders","volume":"112","author":"Higgins","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111706060778000_B13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1537-2995.2006.00764.x","article-title":"Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?","volume":"46","author":"Schonewille","year":"2006","journal-title":"Transfusion"},{"issue":"6","key":"2019111706060778000_B14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1537-2995.2002.00126.x","article-title":"Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications","volume":"42","author":"Castro","year":"2002","journal-title":"Transfusion"},{"issue":"6","key":"2019111706060778000_B15","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/eji.201445187","article-title":"Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients","volume":"45","author":"Vingert","year":"2015","journal-title":"Eur J Immunol"},{"issue":"3","key":"2019111706060778000_B16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2019111706060778000_B17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10875-016-0268-3","article-title":"Human circulating T follicular helper cell subsets in health and disease","volume":"36","author":"Ueno","year":"2016","journal-title":"J Clin Immunol"},{"issue":"11","key":"2019111706060778000_B18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3324\/haematol.2015.132738","article-title":"TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization","volume":"100","author":"Godefroy","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"2019111706060778000_B19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"issue":"8","key":"2019111706060778000_B20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111706060778000_B21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.STR.0000221173.97108.01","article-title":"Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke","volume":"37","author":"Lezcano","year":"2006","journal-title":"Stroke"},{"issue":"12","key":"2019111706060778000_B22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"2019111706060778000_B23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111706060778000_B24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood-2005-02-0494","article-title":"Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression","volume":"106","author":"Chauveau","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111706060778000_B25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.1400105","article-title":"Hemin controls T cell polarization in sickle cell alloimmunization","volume":"193","author":"Zhong","year":"2014","journal-title":"J Immunol"},{"issue":"13","key":"2019111706060778000_B26","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1182\/blood-2012-11-469122","article-title":"Differential control of Helios(+\/-) Treg development by monocyte subsets through disparate inflammatory cytokines","volume":"121","author":"Zhong","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111706060778000_B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur J Haematol"},{"issue":"5","key":"2019111706060778000_B28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"issue":"2","key":"2019111706060778000_B29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ajcp\/56.2.137","article-title":"Plasma hemoglobin and hemoglobin fractions in sickle cell crisis","volume":"56","author":"Naumann","year":"1971","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2019111706060778000_B30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1152\/physrev.00011.2005","article-title":"Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications","volume":"86","author":"Ryter","year":"2006","journal-title":"Physiol Rev"},{"issue":"3","key":"2019111706060778000_B31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)64037-0","article-title":"Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease","volume":"158","author":"Nath","year":"2001","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111706060778000_B32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2003-08-2760","article-title":"Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease","volume":"104","author":"Jison","year":"2004","journal-title":"Blood"},{"issue":"20","key":"2019111706060778000_B33","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1073\/pnas.94.20.10919","article-title":"Heme oxygenase 1 is required for mammalian iron reutilization","volume":"94","author":"Poss","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111706060778000_B34","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.0802436","article-title":"Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity","volume":"182","author":"R\u00e9my","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"2019111706060778000_B35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1254\/jphs.FP0060270","article-title":"Hemin modulates cytokine expressions in macrophage-derived foam cells via heme oxygenase-1 induction","volume":"103","author":"Ma","year":"2007","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"2019111706060778000_B36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0002-9440(10)63365-2","article-title":"Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse","volume":"165","author":"Kapturczak","year":"2004","journal-title":"Am J Pathol"},{"issue":"8","key":"2019111706060778000_B37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1600-0625.2007.00581.x","article-title":"Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells","volume":"16","author":"Listopad","year":"2007","journal-title":"Exp Dermatol"},{"issue":"3","key":"2019111706060778000_B38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/jpet.106.107482","article-title":"Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects","volume":"319","author":"Kruger","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"2019111706060778000_B39","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1096\/fasebj.13.13.1800","article-title":"Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron","volume":"13","author":"Suttner","year":"1999","journal-title":"FASEB J"},{"key":"2019111706060778000_B40","author":"Vichinsky","year":"2012"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/457\/1251305\/hem088432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2016\/1\/457\/1251305\/hem088432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T11:06:33Z","timestamp":1573988793000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2016\/1\/457\/21098\/Immunoregulatory-networks-in-sickle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12,2]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2016.1.457","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}